Jinan Chuangxingwell Biotech Co., Ltd.
Jinan Chuangxingwell Biotech Co., Ltd.
Jinan Chuangxing Weier Biotechnology Co., Ltd. is located in Jinan, the Spring City. It focuses on the field of biological detection, with core emphasis on the R&D, production and sales of biological products related to drug detection for drug control, as well as the provision of relevant technical services. It is a professional enterprise in the field of trace hair drug detection and analysis in China. Adhering to the philosophy of "Leading Technology, Professional Service, and Trustworthiness", the company has gradually built a complete product system and service network.
On November 8th, Jinan Chuangxing Weier Biotechnology Co., Ltd. was officially registered and established with a registered capital of 10 million yuan. Its legal representative is Cui Jianhui, and it is a limited liability company (invested and held by natural persons). The shareholders consist of Cui Jianhui (holding 89% of the shares) and Xian Chunqiang (holding 11% of the shares). The main personnel include Xian Chunqiang as the executive director, Cui Jianhui as the manager, and Sui Gaolin as the supervisor.
At the beginning of its establishment, the company clearly defined its core development direction, focusing on the field of biological detection and prioritizing the layout of products related to hair drug detection. Relying on relevant technical accumulation, it established the development idea of "R&D-driven and Quality-oriented". Initially located in Jinan High-tech Industrial Development Zone, it laid the foundation for subsequent technological R&D and market expansion. At this time, the company had fewer than 50 employees and 2 insured personnel, in a steady start-up stage.
In the initial stage of its establishment, the company defined its core business scope, including technical services, technical development, technical consultation, etc., as well as related businesses such as the production and sales of Class I medical devices, the sales of drug testing instruments, and the sales of special chemical products (excluding hazardous chemicals), laying the groundwork for the subsequent product launch and market layout.
From 2020 to 2022, the company entered a stage of steady start-up and capacity improvement, focusing on promoting the R&D and optimization of products related to hair drug detection, while actively improving enterprise qualifications and enhancing the level of standardized operation.
During this period, the company gradually built a professional R&D team, focusing on tackling key technologies for rapid trace hair drug detection, and initially formed a unique drug detection technology prototype combining colloidal gold and fluorescence analysis, laying a technical foundation for subsequent product iteration. At the same time, the company gradually expanded its product range, starting the R&D and trial production of core products such as hair drug detectors and detection reagents, focusing on optimizing the detection speed and accuracy of products to meet the needs of practical application scenarios such as public security drug control and drug detection.
In terms of qualification construction, the company gradually promoted standardized management and actively applied for various relevant qualifications. During this period, it gradually improved its intellectual property layout, obtained 1 software copyright, and promoted the handling of relevant administrative licenses, accumulating 5 administrative licenses and 3 qualification certificates, providing guarantee for the legal and compliant listing and market promotion of products. In addition, the company gradually aligned with industry standards, promoting the adaptation of products to relevant detection standards of the public security system, and preparing for subsequent entry into the police market.
In the initial stage of market layout, based in Shandong, the company gradually connected with grass-roots public security, judicial and other relevant units, carried out product trials and promotion, accumulated initial market experience and customer feedback, and optimized product and service processes to improve customer service capabilities.
From 2023 to 2024, the company entered a critical stage of product iteration and market expansion, while optimizing the company's governance structure and enhancing its core competitiveness.
In terms of product R&D, the company continued to increase R&D investment, promoted the iteration and upgrading of hair drug detection products, enriched the product system, and gradually launched detection instruments and reagents suitable for different scenarios, including hair preliminary screening drug detectors and colloidal gold detection reagents. The product performance was continuously optimized, and the detection accuracy and operational convenience were significantly improved, which could meet the detection needs of different scenarios such as grass-roots public security police stations and drug rehabilitation centers.
In terms of corporate governance, on April 12th, 2024, the company completed the latest industrial and commercial approval, further optimizing the equity structure and governance system, improving the level of standardized operation of the enterprise, and providing organizational guarantee for subsequent large-scale development. At the same time, the company continued to improve internal management processes, promoting the standardization of R&D, production, sales, after-sales and other links to improve operational efficiency.
In terms of intellectual property and brand building, in May 2024, the company concentrated on applying for 2 trademarks related to "Shaimiqiu", covering the fields of medical devices (Category 10) and advertising sales (Category 35), gradually strengthening the brand layout, with a total of 6 trademark information, further improving the market recognition of products.
In terms of market expansion, the company gradually expanded its business scope, radiating from Shandong to some provinces across the country, connecting with more public security, judicial and other relevant units, accumulating a certain number of customer resources, and gradually improving the market recognition of products.
Since 2025, the company has entered a period of rapid development with market breakthroughs and technological upgrades, focusing on achieving major breakthroughs in market expansion, while promoting technological innovation and preparation for international layout.
In terms of market expansion, on July 30th, 2025, relying on high-quality products and services, the company successfully won the bid for the 2025 Criminal Investigation Consumables Procurement Project of the High-tech Industrial Development Zone Branch of Chengdu Public Security Bureau. This is an important breakthrough for the company in public security system bidding projects nationwide, marking that the company's products have been recognized by the industry authority and further expanding its market influence in the national public security system.
In terms of technological upgrading, the company continued to deepen its focus on hair drug detection technology, further optimized the detection technology, adopted a new type of quantum dot fluorescence method, and achieved a new technological breakthrough. This makes the product easier to operate and the detection results more accurate, which can generate drug concentration detection results of various samples such as hair, cloth, paper, and blood within 10 minutes, adapting to the needs of more complex detection scenarios, and its technical level is at the forefront of the industry.
At the same time, the company further improved its product system, forming a complete hardware product line including trace hair drug detectors, hair grinders, drug detection reagents, constant temperature incubators, etc., and supporting relevant detection software to achieve coordinated development of software and hardware, providing customers with one-stop detection solutions. It can be widely used in public security drug control, drug detection, drug rehabilitation, and hair detection services and other related work.
In terms of long-term planning, based on the existing technology and market foundation, the company has formulated a strategic plan of "entering the international market", gradually sorting out international market access standards, optimizing product adaptability, and planning to expand the global market with advanced detection technology, professional technical guidance and perfect after-sales service, opening a new chapter in international development.
Up to now, Chuangxing Weier Biotechnology has developed into a professional biotechnology enterprise focusing on the field of hair drug detection, accumulating rich technical experience and market resources, with remarkable core development achievements:
1. Qualifications and Intellectual Property Rights: It has 6 trademarks, 1 software copyright, 5 administrative licenses and 3 qualification certificates. Through standardized operation, it has gradually improved its core competitiveness and gained recognition from relevant industry units;
2. Product System: It has built a complete hair drug detection product system, covering detection instruments, reagents, auxiliary equipment and supporting software, forming a unique detection technology system combining colloidal gold and fluorescence analysis, which is suitable for various detection scenarios;
3. Market Layout: It has successfully won bids for national public security system bidding projects, with customers covering public security, judicial and other relevant units in Shandong and some provinces across the country, and the market recognition of products is gradually improving;
4. Industry Positioning: It is a professional provider in the field of trace hair drug detection and analysis technology in China, focusing on providing accurate and efficient detection products and one-stop solutions for public security, judicial and other industries, actively helping the development of drug control cause and providing technical support for building a "drug-free society";
5. Social Responsibility: It actively participates in drug control related work, cooperates with relevant units to carry out detection services related to community drug rehabilitation (recovery), provides technical support for drug addict control, hidden drug use investigation and other work, and fulfills corporate social responsibility.
Summary: Since its establishment in 2019, Chuangxing Weier Biotechnology has always focused on the field of biological detection, with hair drug detection technology as the core, steadily promoting product R&D, qualification construction and market expansion, and gradually growing from a start-up enterprise to a professional enterprise with certain influence in the industry. In the future, the company will continue to be driven by technological innovation, optimize products and services, promote international layout, and strive to achieve greater breakthroughs in the field of hair drug detection, contributing to the development of the global drug control cause.
Follow Official Account
